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Enzyme- and gene-specific biases 
in reverse transcription of RnA 
raise concerns for evaluating gene 
expression
nicola Minshall & Anna Git ✉
Reverse transcription is the first step of most analyses of gene expression, yet the quantitative biases 
it introduces are largely overlooked. following a series of purpose-designed systematic experiments 
we cherry-pick examples of various biases introduced by reverse transcription, and alert the “gene 
expression community” to the pitfalls and improved practice of this fundamental technique.
The analysis of gene expression underpins every aspect of modern biomedical research, which in the last two 
decades has progressed from single-gene to genome-wide approaches. Typically, the relative abundance of specific 
RNAs (or more precisely, the cDNAs corresponding to those RNAs) is enumerated by quantitative PCR (real-time 
PCR; qPCR) or by massively parallel (next-generation; NGS) sequencing. Substantial effort has been invested in 
the assurance of standards for these techniques, including their linearity, positive and negative controls, normal-
isation of data and the recognition of inherent biochemical and computational biases.
In contrast, the initial essential step “converting” the RNA to measurable cDNA, has not been scrutinised with 
the same rigour, and is not subject to an accepted best practice. Although a handful of studies attempted to tackle 
various aspects of reverse transcription pitfalls (reviewed1), the prevalent practice still assumes that manufactur-
ers’ reverse transcription (RT) protocols ensure uniform and reliable synthesis of cDNA. Over the past decade, we 
have accumulated anecdotal, and often contradictory, experience regarding RT non-linearity and biases.
In a series of purpose-designed experiments, we systematically demonstrate that the bias introduced 
by RT is far greater than is commonly assumed. Our data (Supplemental File 1) indicate that RT introduces 
amplicon-specific and transcriptase-specific biases which render standard calculations (e.g. ΔΔCq) of relative 
gene expression inaccurate at best and erroneous at worst. We cherry-pick examples where differential RNA 
integrity or saturation of the RT may falsely appear as differential expression (DE). Lastly, we propose improved 
practices which can easily be integrated into the MIQE guidelines1,2 for RT-qPCR and NGS experimental design 
and reporting.
Results
In order to evaluate the effect of RT on perceived DE, we used total RNA from two cell lines, T-47D (T) 
and Hs578T (H). An aliquot of T RNA has been mildly chemically fragmented (Tf; Figure S1) to mimic the 
low-integrity (partly degraded) RNA often obtained from tissues. Four doses (2-fold: 75, 150, 300, 600 ng) of 
each of the three input RNAs (H, T, Tf) were reverse-transcribed using three common commercial kits. Three 
2-fold dilutions of each of the resulting cDNAs were evaluated by quantitative PCR. The expectation, under ideal 
conditions, is that doubling the RNA input into the RT is equivalent to doubling the cDNA input into the qPCR. 
A hypothetical expected result is shown in Fig. 1.
We examined 8 qPCR amplicons, representing coding (a-d) and non-coding (e-h) transcripts of varying abun-
dance, approximated by relative Cq values. They are: (a) a highly abundant eEF1A1 “exon-exon” amplicon with 
primers on consecutive exons spanning a 366 nt intron (b) a low abundance eEFint amplicon from this eEF1A1 
intron; (c) a moderately abundant OAZ1 “exon-exon” amplicon; (d) a low abundance MVP “exon-exon” ampli-
con; and several non-coding RNAs (ncRNAs; (e) 18 S rRNA, (f) 5.8 S rRNA and (g) U1 snRNA), as well as (h) Alu 
which can be transcribed either as a stand-alone ncRNA or embedded in untranslated regions of coding genes, 
and which has been proposed as a measure of total RNA load instead of unreliable single-transcript RT-qPCR ref-
erence genes3, colloquially referred to as “housekeepers”. Notably, eEF1A1 is our best empirically-derived single 
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reference gene for breast cancer samples, exhibiting the lowest variation across 2,000 breast tumours4 (observa-
tion unpublished), and later validated across multiple breast cell lines (not shown).
The key observations from our systematic analysis are general non-linearity as well as amplicon-specific and 
reverse transcriptase-specific biases. In general, across the entire dataset, a 2-fold increase of cDNA input into a 
qPCR reaction resulted in an average decrease of 0.99 in Cq value (n = 576 2-fold dilution pairs) – in line with 
the theoretical decrease of 1. In contrast, a 2-fold increase of RNA input into an RT reaction led to an average 
decrease of only 0.39 (n = 648) – a substantially lower value than the theoretical decrease. For brevity, hereafter 
we will refer to Cq increase per 2-fold dilution as Cq2f.
A major decision in evaluation of gene expression is the choice of reverse transcriptase enzyme or kit. This 
decision is typically a matter of lab tradition and cost, and is seldom evaluated when experimental designs 
change5. Figure 2 highlights kit-dependent biases in RT-qPCR analysis. It presents Cq values obtained in the 
analysis of Alu, 5.8 S and U1 amplicons in dilutions of RNA from a single cell line (H), reverse-transcribed using 
two commercial RT kits: iScript and Transcriptor. These amplicons yield similar Cq values (by proxy: similar 
abundance), thus ruling out major discrepancies due to stoichiometry. Predictably, the titration of all individual 
cDNAs into the qPCR consistently resulted in Cq changes (~1 Cq2f; compare to solid green line in Fig. 1). In 
contrast, the titration of RNA into iScript RT led to “compressed” but consistent Cq increase in 5.8 S (0.45 ± 0.02 
Cq2f), but not U1 amplicons (0.13 ± 0.04 Cq2f), while a similar titration into Transcriptor RT led to increase 
in U1 (0.56 ± 0.06 Cq2f) but not 5.8 S Cq values (0.07 ± 0.12 Cq2f). The Cq values for Alu (and other tested 
Figure 1. A schematic of the experimental design and Cq values of a hypothetical ideal qPCR amplification. A 
series of 2-fold dilutions of an RNA sample are reverse transcribed (RT), and 2-fold dilutions of each resulting 
cDNA are analysed by qPCR. Colour intensity of tube (left) and corresponding circle (right) represents 
predicted amplicon abundances. Samples boxed in blue (left and right) exemplify a set of samples expected to 
harbour identical Cq values. Relative input quantities are depicted as black steps (right; not to scale). Solid green 
lines connect samples of one ideal qPCR titration curve (-1 Cq per 2-fold increased input of cDNA in qPCR). 
Solid pink lines connects the samples of a similar ideal RT titration curve (-1 Cq per 2-fold increased input of 
RNA in RT).
Figure 2. qPCR analysis of RNA H using two RT kits (iScript and Transcriptor). Experimental setup and 
display are as in Fig. 1. Solid lines are average RT titration slopes. For precise values, see text.
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amplicons; Supplemental File 1) behaved consistently in both RT systems (increase of 0.65 ± 0.02 and 0.73 ± 0.03 
Cq2f, respectively). Similarly, among the coding mRNAs, MVP RT-qPCR is insensitive to RNA titration into the 
iScript RT (0.23 ± 0.09 Cq2f) while eEF1A1 RT-qPCR responds better (0.51 ± 0.09 Cq2f). Thus, applying the 
ΔΔCq method, there is an apparent DE (>5-fold) of MVP relative to eEF1A1 between dilutions of the same 
RNA. This is not due to problems with the amplicon or the target mRNAs as when using Transcriptor RT, the 
maximal apparent DE between RNA dilutions is 1.6-fold.
An added complication in studies of gene expression in patient tissues, is inconsistent RNA integrity across the 
sample cohort6. This can represent an inherent biological truth (e.g. native, necrotic or inflammatory RNase activ-
ity), or can be the artifact of variable sample storage and processing (e.g. time taken to freeze biopsies, or slower 
lysis of fibrotic samples). Figure 3 illustrates the biases in RT-qPCR analyses of our model RNAs of different integ-
rity from the same sample: intact (T) and partly-degraded (Tf). As expected, most amplicons (here: MVP, eEF1A1 
and eEFint) yield a slightly higher Cq value in Tf, due to the lower abundance of intact RT template (eEF1A1 Cq 
values increase by 2.00 ± 0.43; MVP1 by 0.94 ± 0.42; eEFint by 1.68 ± 0.28. Coloured arrows in the figure indicate 
the trend of change for one highlighted dilution). In contrast, the Cq values of the U1 amplicon are decreased by 
0.68 ± 0.14 (grey arrow) by compromised template integrity. This can be hypothetically attributed to the struc-
tured nature of the U1 snRNA and thus higher resistance to chemical cleavage – raising possible concerns about 
the use of U1 and other structured RNAs as reference genes7. A more subtle effect is evident when normalising 
MVP or eEFint amplicon values to the eEF1A1 reference amplicon, yielding a false DE of ~2-fold up-regulation 
between intact and fragmented samples of the same RNA. Since SuperScript-IV RT-qPCR (another commercially 
available RT kit) analysis of the same samples was not similarly skewed, we assume that this bias is not inherent to 
the presented amplicons, e.g. 5'/3' bias in samples degraded by exonucleolytical activity in vivo or in preparation6.
We then used the data obtained in the titration experiment for a typical analysis of differential expression, as 
is the common practice across hundreds of research papers. Figure 4 presents the analysis of relative expression 
of two coding genes, OAZ1 and eEF1A1, in intact RNA from H and T cell lines. To estimate OAZ1 levels relative 
to the eEF1A1 reference, average Cq values obtained in quantitative PCR of iScript RT reactions performed 
with either 75 ng or 600 ng RNA were subjected to ΔΔCq calculation. The resulting estimate is 2-fold different 
between sample pairs of varying RNA input. Importantly, while the use of a single reference gene is ill-advised, 
and should be substituted by a rationalised or empirically-defined set of reference genes to dampen technical and 
biological spurious readings, the measurement of the gene of interest is always subject to biases which cannot be 
mitigated.
Lastly, we examined the potential contribution of the aforementioned biases on reverse transcription used 
in the generation of libraries for RNA-seq. To this end, we have set up a similar titration experiment using the 
Figure 3. qPCR analysis of intact (T) and partly-degraded (Tf) RNA T using Transcriptor. Experimental setup 
and display are as in Fig. 1. Arrows exemplify the trend of change in Cq values using the highlighted dilution 
(outlined circles).
RNA     ng  Average CqeEF1A1 
 Average Cq
OAZ1 
∆Cq
OAZ1-eEF1A1 
∆∆Cq
RNA T-H 
H 21.20                 2.34
T 21.63                 2.58
H 19.99                 2.72
T 20.86
               23.54
               24.21
               22.72
               24.64                3.78
0.24
1.06
75
600
Figure 4. qPCR analysis of RNA from two cell lines (H and T) using iScript RT performed with either 75 or 
600 ng RNA. Differential expression of OAZ1 relative to eEF1A1 is calculated using the ΔΔCq method.
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SuperScript-II protocol and reagents from the Illumina’s TruSeq® Stranded Total RNA Sample Preparation Guide. 
To rule out the contribution of potential contaminants due to our RNA extraction techniques, we processed 
alongside H and T cell line RNAs similar quantities of Stratagene QPCR Human Reference Total RNA (U), which 
is a high-quality commercial control RNA recommended for quantitative PCR gene-expression analysis. Each 
75–600 ng sample was tested with or without associated TruSeq fragmentation (Hf, Tf or Uf RNAs, respectively).
Figure 5 summarises the average Cq values obtained in this experiment, as well as the difference in Cq 
obtained for 2-fold input dilutions in RT or qPCR for each amplicon. We confirm the key findings listed above. 
In particular, the overall average change in Cq for a 2-fold dilution of RT input into qPCR is 1.01 ± 0.17 (n = 384) 
while that of a 2-fold dilution of RNA input into an RT is 0.62 ± 0.31 (n = 432). The latter value can be as low as 
0.13 ± 0.21 Cq2f for 5.8 S rRNA (n = 54; turquoise), despite the qPCR titration for the same amplicon showing 
1.03 ± 0.19 Cq2f. The poor RT dependency of 5.8 S on RNA input is visible in all intact as well as fragmented 
RNAs. Interestingly, in contrast to the fragmentation used in the previous experiment (Fig. 3), the RT dependency 
of U1 is vastly improved upon TruSeq fragmentation (from 0.15 ± 0.16 to 0.58 ± 0.03 Cq2f; grey). Unfortunately, 
due to the proprietary nature of the reagents, we are unable to speculate as to the reason. Lastly, similarly to the 
findings of Fig. 3, amplicons are differently affected by RNA fractionation. Simplistic ΔΔCq analysis of MVP 
(orange) or eEFint (blue) amplicons relative to eEF1A1 (green), can yield a perceived DE of up to 2.4-fold between 
intact and fragmented pairs of identical RNA inputs. There is no obvious difference between the behaviour of any 
tested amplicon between commercial RNA (U) or those prepared in the lab, suggesting that the reported biases 
cannot be attributed to preparation methods.
Discussion
These systematic data corroborate our (and colleagues’) cumulative anecdotal experience involving >100 ampli-
cons (including several bacterial genes as well as many eukaryotic project-specific coding genes; commonly 
used reference genes, such as GAPDH, ACTB, HPRT1, 18 S and 5 S ribosomal RNA, U6 snRNA, U44 snoRNA; 
and various microRNA genes) across thousands of samples and dozens of experimental designs. Differential 
dose-response – and ultimately saturation – of RT reactions is far more prevalent than is commonly assumed, 
even within manufacturers’ usage parameters. In line with published observations of lower reproducibility of RT 
compared to qPCR8, in our experience RT biases lead to far greater errors than qPCR imperfections, especially 
when users adhere to MIQE-based practices for qPCR. Amplicon-dependent biases within a chosen RT system 
can identify non-existent DE or mask real effects. Moreover, RT is the founding step in many cutting edge tech-
nologies, such as single-cell expression analysis. Leaving its biases untested undermines such advances.
We cannot pinpoint a single factor, either in the nature of the qPCR amplicon or the RT procedure, which can 
alleviate all these biases. In addition to critical evaluation of available reverse transcriptases5, in our experience, 
the maximal RNA input suggested by all manufacturers is too high; and the most substantial – although by no 
Figure 5. qPCR analysis of RNA from two cell lines (H and T) as well as a commercial reference (U) with or 
without fragmentation (fragmented: Hf, Tf and Uf). Experimental setup and display are as in Fig. 1. Amplicon 
colour-coding is as in Figs. 2 and 3. Samples boxed in blue exemplify sets of U1 samples expected to harbour 
identical Cq values (see Fig. 1). Arrows illustrate the shift in Cq of two amplicons upon fragmentation of each of 
the three tested RNAs.
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means complete – improvement to RT biases is achieved by reducing the RNA input at the cost of higher eventual 
Cq values.
Many additional hypothetical factors can play a role in differential RT efficiency or imperfect dose depend-
ence. In addition to their implication on optimal primer design1, secondary structures may lead to differential 
denaturation of RNA templates at the RT temperature. This bias can easily be minimised by avoiding one-step 
RT-qPCR methods1 and by using a thermostable RT enzyme at a higher temperature. Unfortunately, the effect of 
the same structures on differential degradation in vivo or during RNA extraction cannot be as easily moderated.
In the absence of secondary structure, primary sequence may play an under-researched role in RT efficiency. 
Features such as GC-content and repeat sequences are well known to cause “difficult regions” in PCR amplifica-
tion, and numerous simple or proprietary additives exist to alleviate these difficulties in PCR. It stands to reason 
that similar effects will take place at the RT step. The use of random hexamers for priming RT throughout the 
entire length of RNAs poses additional challenges. These are not only dependent on local GC-content, but certain 
hexamer variants may be sequestered by abundant transcripts, thus causing a non-linear stoichiometry for less 
abundant transcripts. Manufacturers are invited to re-evaluate their protocols, perhaps using synthetic transcripts 
in varying mixed RNA backgrounds.
The incorporation of multiple rationalised9 reference “housekeeping” amplicons, as recommended by the 
MIQE guidelines2, can dampen the effect of some amplicon-specific problems. We further advocate restricting 
the use of ΔΔCq-like approaches based on reference amplicons to fine-tuning of minor fluctuations (<1.5-fold 
or ΔCq = 0.58) in RNA input. We strongly advise including reference RNA titration curves in the RT step, much 
like the DNA (or cDNA) titration curves required under the MIQE guidelines for correcting qPCR analyses of 
amplicons with differential amplification efficiency. Moreover, where sample availability and budgets allow, RT 
of key biological samples should not only be replicated to account for RT variability8, but also carried out with 
varying RNA inputs to ensure that perceived DE is dose-independent.
Lastly, we have used qPCR to demonstrate specific RT biases generated by kits aimed at single-gene and 
genome-wide readouts alike. False-positive and false-negative outcomes of biased RT may be greater on a 
genome-wide scale, and the RNA community will greatly benefit from an appropriately directed analysis of rele-
vant NGS datasets. Complementary efforts from the manufacturers of RT kits are also called for.
Materials and Methods
RnA extraction and fragmentation. Total RNA was isolated from T-47D and Hs578T adherent breast 
cancer cell lines using Direct-zol (Zymo R2052), including the optional DNase treatment step. Stratagene 
Human Reference Total RNA (#750500), a pool of 10 human cell lines certified for use in qPCR, was purchased 
from Agilent. For Experiment 1, 10 µg aliquots were fragmented using RNA Fragmentation Reagents (Thermo 
AM8740) for 50 sec at 70 °C or 0 °C to generate matched part-fragmented or intact samples, respectively. RNA 
was re-purified using Direct-zol. For Experiment 2, fragmentation was carried out as part of the TruSeq Stranded 
Total RNA protocol (see below). Equal load and integrity of all input RNAs were confirmed by electrophoresis 
through an agarose gel impregnated with SYBR Safe (Thermo) followed by imaging under blue light (Figure S1).
Reverse transcription. Aliquots of 600, 300, 150 or 75 ng of each RNA, alongside a sample containing 
only water (RT0; to control for contamination of reagents), were reverse-transcribed using one of four systems: 
Transcriptor (Roche), SuperScript IV (ThermoFisher), iScript (BioRad) or SuperScript II (ThermoFisher; using 
Illumina TruSeqStranded Total RNA reagents and protocols), essentially following manufacturers’ recommenda-
tions while keeping optional choices (e.g. primers, or pre-RT heat-denaturation of RNA) as consistent as possible. 
For each system, a pool of 200 ng of each of the RNAs was also treated alongside individual samples with the 
omission of the enzyme (RT-; to estimate possible contribution of traces of genomic DNA to quantitative PCR 
amplification). To minimise error (e.g. pipetting of small volumes), all non-template reagents were combined into 
master mixes.
Transcriptor. 1 µl of 10 µM T15VN and 1.5 µl of 100 µM N6 primers were added to the RNA in a final volume of 
13 µl. Following denaturation for 10 min at 65 °C, samples were snap-cooled on ice and supplemented with 4 µl 5x 
Transcription Reaction Buffer, 0.5 µl RiboLock RNase Inhibitor (ThermoFisher EO0381), 2 µl 10 mM dNTP and 
0.5 µl Transcriptor enzyme. Reverse transcription was initiated for 10 min at 25 °C, proceeded for 30 min at 55 °C 
and finally terminated by incubating for 5 min at 85 °C.
SuperScript IV. 1 µl of 10 µM T15VN, 1.5 µl of 100 µM N6 primers and 1 µl 10 mM dNTP were added to the RNA 
in a final volume of 13 µl. Following denaturation for 10 min at 65 °C, samples were snap-cooled on ice and sup-
plemented with 4 µl 5x SSIV Buffer, 1 µl RiboLock RNase Inhibitor, 1 µl dithiothreitol (DTT) and 1 µl SuperScript 
IV enzyme. Reverse transcription was initiated for 10 min at 25 °C, proceeded for 30 min at 55 °C and finally 
terminated by incubating for 5 min at 85 °C.
iScript. RNA alone, in a final volume of 15 µl, was denatured for 10 min at 65 °C and snap-cooled on ice. 
Following the addition of 4 µl 5x iScript Mastermix and 1 µl iScript enzyme, reverse transcription was initiated for 
10 min at 25 °C, proceeded for 30 min at 46 °C and finally terminated by incubating for 1 min at 95 °C.
SuperScript II. RNA alone, in a final volume of 8.5 µl, was mixed with 8.5 µl of Illumina Elute, Prime, Fragment 
High Mix and incubated either at 94 °C for 8 min or at 65 °C for 10 min, resulting in fragmented or intact tem-
plates, respectively. Following snap-cooling and addition of 7.2 µl of First Strand Synthesis Act D Mix and 0.8 µl 
SuperScript II enzyme, reverse transcription was initiated for 10 min at 25 °C, proceeded for 15 min at 42 °C and 
finally terminated by incubating for 15 min at 70 °C.
6Scientific RepoRtS |         (2020) 10:8151  | https://doi.org/10.1038/s41598-020-65005-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
Quantitative pcR. Experimental procedure. A 15 µl aliquot of each reverse transcription reaction was 
diluted 20-fold. Two additional 2-fold serial dilutions were made for all samples except RT0 and RT- samples. 
8 µl quantitative PCR reactions in 384-well plates contained 4 µl diluted cDNA (equivalent to 0.2, 0.1 or 0.05 µl of 
the RT reaction, depending on the dilution) and 4 µl of either FAST SYBR Green Master Mix or PowerUp SYBR 
Green Master Mix (Applied Biosystems 4385612 or A25780, respectively; supplied as a 2x concentrate) supple-
mented with 1 µM each primer (listed in Table 1) to a final concentration of 500 nM primers in the reaction. 
Cycling was carried out on a CFX384 (Bio-Rad) or QuantStudio 5 (ThermoFisher) machine. Cycling param-
eters (as recommended by Applied Biosystems) included an initial denaturation at 95 °C for 20 sec, 40 cycles 
of 2-step amplification comprised of touch denaturation (1 sec) at 95 °C and extension with data collection at 
60 °C for 20 sec, and a melt curve analysis based on slow renaturation and denaturation between 60 °C and 95 °C. 
Quantification cycle (Cq) was determined by the manufacturer’s software using automatic settings. Manual selec-
tion of thresholds for Cq determination introduced only insubstantial differences into the presented analyses, 
conclusions and recommendations.
Quality control. The existence of a single end product was verified by melt-curve analysis, and the end product 
of selected qPCR reactions was confirmed by electrophoresis through an agarose gel impregnated with SYBR Safe 
(Thermo) followed by imaging under blue light (Figure S2). Alu amplification results from a large number of tem-
plates and therefore produces a broader melting peak and minor bands in addition to the main product. A sample 
of normal genomic DNA (Cambio CA-972-F) was analysed alongside cDNA as an additional control to ensure 
no cross-intron amplification. To minimise error all reactions have been set up using single- or multi-channel 
electronic repeat pipettors, and avoiding pipetting volumes <1 µl. No substantial readings were obtained in RT0 
and RT- negative control samples.
Data preprocessing. All reactions were set up in triplicate. For simplicity and consistency of removing aberrant 
qPCR wells (e.g. containing dust or bubbles), downstream analyses were performed using the average of the 
two closest triplicates. Using a median or average of all three replicates introduced only insubstantial differ-
ences into the presented analyses, conclusions and recommendations. The standard deviation across triplicates 
was 0.19 ± 0.27 Cq, and across best duplicates −0.06 ± 0.10 Cq (representing duplicates with Cq difference of 
0.09 ± 0.14), with high standard deviations mostly affecting readings with Cq >30 (single-molecule stochastic 
readings), such as negative controls. For clarity of presentation, error bars depicting the standard deviation were 
omitted throughout the manuscript.
primers. All primers were designed using the Primer3 algorithm at http://bioinfo.ut.ee/primer3-0.4.0/
primer3/ using default parameters (60 °C optimal melting temperature, 18–27 nt primer) to result in a 70–110 bp 
amplicon suitable for fast quantitative PCR amplification.
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Primer Purpose Sequence (F) Sequence (R)
Amplicon 
size cDNA 
(gDNA)
T15VN
Clamped oligo(dT) for 
reverse transcription 
of 3' termini of 
polyadenylated RNA
TTTTTTTTTTTTTTTVN V = [A, C, 
G] N = [A, C, G, T] N/A N/A
N6
Random Hexamers for 
reverse transcription 
throughout all RNA
NNNNNN N = [A, C, G, T] N/A N/A
eEF1A1 qPCR of eEF1A1 cDNA (exon-exon junction) GGCATCGACAAAAGAACCAT CCCAGGCATACTTGAAGGAG 79 (79*, 445)
eEFint qPCR of eEF1A1 cDNA (intronic) TGGTTGCTTCTGTAACCCAAA CAGCCCTTAATTGGCAGTTT 79 (79)
OAZ1 qPCR of OAZ1 cDNA (exon-exon junction) GCTCCTAAGCCTGCACAGC GACCCGGGTTACTACAGCAG 80 (1720)
MVP/LRP qPCR of MVP/LRP cDNA AGGCCAAGCTAAAAGCACAG AGCTCTCGGACCTTCTGGAC 76 (988)
18 S rRNA qPCR of 18 S rRNA cDNA CTGGATACCGCAGCTAGGAA ATCATGGCCTCAGTTCCGAA 75 (75)
5.8 s rRNA qPCR of 5.8 S rRNA cDNA GGTGGATCACTCGGCTCGT GCAAGTGCGTTCGAAGTGTC 102 (102)
U1 qPCR of U1 snRNA cDNA CCATGATCACGAAGGTGGTTT ATGCAGTCGAGTTTCCCACAT 101 (101)
Alu qPCR of Alu cDNA CATGGTGAAACCCCGTCTCTA GCCTCAGCCTCCCGAGTAG 90–93 (90–93)
Table 1. Primer sequences. *Processed pseudogenes.
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